Hempire Labs expands its GMP laboratory design services, helping medical cannabis producers plan pharmaceutical-standard facilities with compliant workflows, cleanroom engineering, and infrastructure designed to support regulatory inspections.

Sotogrande, Spain, September 14, 2026 -- Hempire Labs has expanded its GMP-compliant laboratory design and consulting services for medical cannabis producers developing pharmaceutical-standard production facilities. The consultancy supports licensed operators with facility planning, cleanroom engineering, process design, and compliance considerations intended to prepare operations for regulatory inspection.

For more information, visit https://hempirelabs.com

The expansion comes as pharmaceutical manufacturers continue to operate under detailed requirements. The European Commission's EudraLex Volume 4 GMP framework covers areas including premises and equipment, production, quality control, self-inspection, and qualification and validation, making facility design an important consideration long before an inspection takes place.

Hempire Labs applies this regulatory perspective to laboratory and production facility design, helping operators consider compliance requirements during the planning stage rather than addressing them after construction. Its consulting services can encompass laboratory layouts, cleanroom environments, equipment positioning, personnel and material flows, process requirements, and other elements that influence controlled pharmaceutical production.

For medical cannabis operations, the applicable requirements can also change as plant material moves through cultivation, primary processing, extraction, and pharmaceutical manufacturing. EMA guidance addresses Good Agricultural and Collection Practice (GACP) for the cultivation, collection, and primary processing of medicinal plants, while GMP requirements become relevant according to the subsequent processing stage and intended medicinal product.

Hempire Labs therefore advises clients on GMP- and GACP-aligned facility planning across cultivation, extraction, processing, and laboratory operations. By considering regulatory requirements alongside workflows and physical infrastructure, the consultancy helps businesses identify potential design conflicts before facilities become operational and changes become more complex or costly to implement.

Audit readiness is also influenced by how effectively the facility supports its intended processes. Appropriate segregation, controlled movement of personnel and materials, contamination controls, cleanability, utilities, equipment placement, and qualification requirements can all affect whether the physical environment supports the site's pharmaceutical quality system.

Founded in 2019, Hempire Labs provides lab consulting, pharmaceutical lab design services, cleanroom engineering, and project support for licensed producers worldwide. Its work spans cultivation facilities through extraction and processing environments, with projects developed around applicable pharmaceutical and medicinal-plant standards.

Producers planning new laboratories or reviewing existing facilities can learn more about Hempire Labs' laboratory design and compliance consulting services at https://hempirelabs.com

Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: C.C., Mar y Sol Local 3.9, Sotogrande, Andalucía 11310, Spain
Website: https://hempirelabs.com

Source: NewsNetwork

Release ID: 89203226

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.